药物对比
Canagliflozin vs Insulin Glulisine Human
Canagliflozin（Invokana）与Insulin Glulisine（Apidra）：口服SGLT2抑制剂与速效胰岛素。比较两者在2型糖尿病与1型糖尿病中的用途、机制及给药方式。
此页面暂无可用的对比维度。
临床背景
This comparison arises when deciding between continuing oral SGLT2 inhibitor therapy or initiating rapid-acting insulin in progressing type 2 diabetes or when managing type 1 diabetes.
结论
Neither is better overall because they address different diabetes types and treatment stages via unrelated mechanisms.
全部药物对比